Fig. 6From: PFP@PLGA/Cu12Sb4S13-mediated PTT ablates hepatocellular carcinoma by inhibiting the RAS/MAPK/MT-CO1 signaling pathwayHyperthermia inhibits growth of HCC in vivo. A Representative images of tumors implanted with HepG2 and Huh7 cells by US imaging at the 14th and 21st day. (Left panel represents the control and right panel represents the 50 °C treatment, and arrows indicate US imaging of the corresponding tumors). B Representative images of tumors by MRI at the 14th day and 21st day. The arrows indicating the location of tumors. C The photographs of excised tumors at the 21st dayBack to article page